Thermo Fisher Scientific TMO
NYSE TMO
$659.18 +10.75 (+1.66%)
As of: Sep 17, 2026 · 3:59 PM EDT

Thermo Fisher Scientific (TMO) EBT Margin Growth (3y) (2012 - 2026)

Analysis

Thermo Fisher Scientific (TMO) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 266.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -211.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1,575.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3,000.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -138.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -730.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 30,357.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -871.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 2,904.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -1,462.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 266.00
Mar 28, 2026 303.00
Dec 31, 2025 211.00
Sep 27, 2025 142.00
Jun 28, 2025 -173.00
Mar 29, 2025 -586.00
Dec 31, 2024 -36.00
Sep 28, 2024 -690.00
Jun 29, 2024 -535.00
Mar 30, 2024 -1,243.00
Dec 31, 2023 -1,148.00
Sep 30, 2023 -974.00
Jul 1, 2023 -473.00
Apr 1, 2023 -56.00
Dec 31, 2022 29.00
Oct 1, 2022 189.00
Jul 2, 2022 -458.00
Apr 2, 2022 815.00
Dec 31, 2021 185.00
Oct 2, 2021 965.00